期刊文献+

我院儿科门诊糖皮质激素应用合理性分析 被引量:4

Rationality Analysis of Glucocorticoid Application in Pediatric Outpatient Department of Our Hospital
原文传递
导出
摘要 目的:了解我院儿科门诊糖皮质激素的应用现状及合理性,为临床合理用药提供参考。方法:抽取我院2019年1—12月儿科门诊使用糖皮质激素的处方共计1 200张,对糖皮质激素的使用情况及合理性进行统计与分析。结果:我院儿科门诊使用的糖皮质激素共5种,频次最多的为地塞米松注射液(42.82%),主要疾病诊断为支气管炎(32.83%)。1 200张处方中466张为不合理用药,不合理用药率为38.83%,主要为适应证不适宜和药物剂型或给药途径不适宜。结论:我院儿科门诊糖皮质激素的使用仍存在较多不合理用药的情况,需加强培训和管理,提高临床应用合理性。 Objective:to understand the application status and rationality of glucocorticoids in pediatric outpatient department of our hospital,and to provide reference for clinical rational use of drugs.Methods:A total of 1 200 prescriptions of glucocorticoids used in outpatient department of Pediatrics in our hospital from January to December 2019 were selected to analyze the use and rationality of glucocorticoids.Results:There are 5 kinds of glucocorticoids used in the pediatric clinic of our hospital,the most frequent one is dexamethasone injection (42.82%),and the main disease is bronchitis (32.83%).Of the 1 200 prescriptions,466 were irrational,the rate of which was 38.83%,mainly due to the unsuitable indications and dosage forms or routes of administration.Conclusion:there are still many unreasonable use of glucocorticoids in pediatric outpatient department of our hospital.It is necessary to strengthen the training and management to improve the rationality of clinical application.
作者 殷扬 李慧侠 张巽维 YIN Yang;LI Huixia;ZHANG Xunwei(Pharmaceutical Department of Zaozhuang Mining Group Central Hospital,Zaozhuang 277800)
出处 《中国药物滥用防治杂志》 CAS 2020年第5期289-291,共3页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 糖皮质激素 合理用药 分析 glucocorticoid rational drug use analysis
  • 相关文献

参考文献9

二级参考文献72

  • 1罗慰慈.糖皮质激素的合理应用[J].中国医院用药评价与分析,2004,4(5):299-299. 被引量:16
  • 2杨岫岩.如何合理应用肾上腺皮质激素[J].新医学,2006,37(3):194-195. 被引量:17
  • 3王立波.儿童慢性咳嗽的病因及治疗[J].实用儿科临床杂志,2006,21(4):194-196. 被引量:47
  • 4郭嘉隆,马翠丽,毕黎琦.糖皮质激素的通用原则[J].中国社区医师,2006,22(6):22-23. 被引量:9
  • 5袁欣,林衍生.我院糖皮质激素类药物应用分析[J].中国药业,2007,16(11):34-36. 被引量:5
  • 6陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 7李俊.临床药理学[M].4版.北京:人民卫生出版社,2011:458-459.
  • 8Atkins D, Briss PA, Eccles M, et al. Systems for grading the quality of evidence and the strength of recommendation Ⅱ: pilot study of a new system[ J]. BMC Health Serv Res,2005,5 ( 1 ) :25.
  • 9Schimmer BP, Parker KL. Adrenocorticotropic hormone : Adrenocorti- cal steroids and their synthetic analogs, inhibitors of the synthesis and actions of adrenocortical hormones [ M ].//Hardman JC, Limbird LE,Molinoff BP, et al. The phamacological basis of therapeutics. New York : McGraw-Hill, 1996 : 1459-1485.
  • 10国家药典委员会中华人民共和国药典.临床用药须知.化学和生物制品卷[S].北京:人民卫生出版社,2005:437.

共引文献2941

同被引文献62

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部